We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

664 hedge funds and large institutions have $10.8B invested in Charles River Laboratories in 2024 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 266 increasing their positions, 235 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 266 | Existing positions reduced: 235

0.06% less ownership

Funds ownership: 101.79% → 101.73% (-0.06%)

6% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 79

2% less funds holding

Funds holding: 676 → 664 (-12)

15% less call options, than puts

Call options by funds: $54.2M | Put options by funds: $63.4M

23% less capital invested

Capital invested by funds: $14.1B → $10.8B (-$3.32B)

47% less funds holding in top 10

Funds holding in top 10: 15 → 8 (-7)

Holders
664
Holders Change
-12
Holders Change %
-1.78%
% of All Funds
9.59%
Holding in Top 10
8
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-46.67%
% of All Funds
0.12%
New
74
Increased
266
Reduced
235
Closed
79
Calls
$54.2M
Puts
$63.4M
Net Calls
-$9.19M
Net Calls Change
+$37.2M

Top Buyers

1
SCA
Southpoint Capital Advisors
New York
+$102M
2
Marshall Wace
Marshall Wace
United Kingdom
+$36.9M
3
1832 Asset Management
1832 Asset Management
Ontario, Canada
+$36.3M
4
MDSL
M.D. Sass LLC
New York
+$36.1M
5
Allspring Global Investments
Allspring Global Investments
North Carolina
+$30.1M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$154M
2
MBI
Montrusco Bolton Investments
Quebec, Canada
-$133M
3
William Blair Investment Management
William Blair Investment Management
Illinois
-$98.8M
4
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans
Minnesota
-$43.3M
5
ClearBridge Investments
ClearBridge Investments
New York
-$32.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
BTW
51
Boston Trust Walden
Massachusetts
$41.4M +$1.22M +5,375 +3%
VOYA Investment Management
52
VOYA Investment Management
Georgia
$40.4M -$1.17M -5,149 -3%
ACM
53
American Capital Management
New York
$37.9M – – –
Fisher Asset Management
54
Fisher Asset Management
Washington
$37.8M -$351K -1,549 -0.8%
JSP
55
Jackson Square Partners
California
$36.8M -$16.6M -73,082 -29%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$36.3M +$526K +2,321 +1%
ERSOT
57
Employees Retirement System of Texas
Texas
$35.9M – – –
Barclays
58
Barclays
United Kingdom
$34.1M +$11.7M +51,731 +46%
PFM
59
Premier Fund Managers
United Kingdom
$33.2M – – –
HKAM
60
Horizon Kinetics Asset Management
New York
$33.1M +$265K +1,170 +0.7%
1832 Asset Management
61
1832 Asset Management
Ontario, Canada
$33.1M +$36.3M +160,000 New
Swiss National Bank
62
Swiss National Bank
Switzerland
$31.4M -$340K -1,500 -1%
ACB
63
Aristotle Capital Boston
Massachusetts
$31.1M +$479K +2,115 +1%
CIBC Private Wealth Group
64
CIBC Private Wealth Group
Georgia
$31M +$1M +4,418 +3%
UBS Group
65
UBS Group
Switzerland
$30.3M +$5.73M +25,295 +21%
ACM
66
Argent Capital Management
Missouri
$30M -$429K -1,895 -1%
MPIA
67
Mountain Pacific Investment Advisers
Idaho
$29.4M -$417K -1,842 -1%
Deutsche Bank
68
Deutsche Bank
Germany
$28.8M -$1.65M -7,262 -5%
SCM
69
Snyder Capital Management
California
$28M -$567K -2,503 -2%
KBC Group
70
KBC Group
Belgium
$27.9M -$168K -741 -0.5%
NPF
71
Norris Perne & French
Michigan
$27M +$432K +1,907 +1%
N
72
Nuveen
North Carolina
$26.9M -$1.04M -4,578 -3%
TCM
73
TimesSquare Capital Management
New York
$26.7M -$1.31M -5,795 -4%
PI
74
PineBridge Investments
New York
$26.5M +$1.02M +4,497 +4%
BNP Paribas Financial Markets
75
BNP Paribas Financial Markets
France
$26.4M +$13.7M +60,682 +90%
1 2
3
4 5

CRL Hedge Fund Activity: Q2 2024 in Review

664 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2024, worth a combined $10.8B — down 23% from $14.1B a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of CRL and 74 opened new positions — a net loss of 5 holders — while 235 trimmed existing stakes and 266 added.

The largest buyer was Southpoint Capital Advisors, adding an estimated $102M. The largest seller was T. Rowe Price Associates, cutting an estimated $154M.

  • 664 institutional investors held Charles River Laboratories (CRL) as of Q2 2024, down from 676 in Q1 2024.
  • Funds reported $10.8B of Charles River Laboratories stock for Q2 2024, down 23% quarter-over-quarter.
  • 74 funds opened new Charles River Laboratories positions in Q2 2024 and 79 closed out, a net change of -5 holders.
  • The largest Charles River Laboratories buyer in Q2 2024 was Southpoint Capital Advisors, an estimated $102M added.
  • The largest Charles River Laboratories seller in Q2 2024 was T. Rowe Price Associates, an estimated $154M sold.

Based on aggregated 13F filings for Q2 2024.